VieCure Aligns with Oncology Care Partners to Accelerate the Adoption of Value-Based Cancer Care

VieCure announced a new strategic partnership with value-based care organization, Oncology Care Partners (“OCP”), which will assist OCP in its provision of world-class care to patients across its growing U.S. network. This collaboration will support OCP’s providers in creating personalized treatment plans using VieCure’s Halo Intelligence Platform and help OCP to advance its commitment to overall health equity for the patients that they serve. This partnership will be impactful as both companies are dedicated to revolutionizing the way that cancer patients are treated. OCP is committed to a new generation of cancer care, ensuring that patients are treated with “whole-person care,” giving them the opportunity to ensure the patient and family will be supported and engaged throughout the entire care process. Currently, OCP has opened its initial practice in Phoenix, Arizona, and is caring for Medicare Advantage patients in the surrounding area. It has also recently acquired an existing practice in Miami, where it will bring its value-based care model to patients in South Florida. OCP is in the process of expanding to deliver world-class, community-based care throughout the country while striving for more efficient and individualized treatment options, and VieCure is proud to power all practices in its growing network. OCP is working to reduce unnecessary services which can in turn lower costs and lower the burden placed on patients. Value-based care will ensure that patients receive the most comprehensive and efficient care, and in turn, improve the overall quality of life for patients and their families.

Recommended AI News: EIPGRID and Intertrust Partner to Deliver Secure Virtual Power Plant Platform

“We view VieCure as an important strategic partner, we share a mission: to make cancer care better for patients. As this partnership grows, we have the opportunity to accelerate growth for both companies and, by extension, the positive impact on cancer patients”

“We view VieCure as an important strategic partner, we share a mission: to make cancer care better for patients. As this partnership grows, we have the opportunity to accelerate growth for both companies and, by extension, the positive impact on cancer patients,” said Joe Pietrzak, Oncology Care Partners CFO, and head of development.

VieCure has developed a proprietary artificial intelligence informatics software platform and combined it with a clinical inference engine, a codified content library, a patient mobile app, a physician mobile app, integrated Tele oncology, and a fulsome data and analytics solution. This comprehensive suite, all tethered to the A.I. clinical inference engine, is the market-leading point-of-care clinical decision support system in oncology. VieCure will also codify the New Century Pathways in algorithms for use by clinicians at OCP practices.

Recommended AI News: Axiom Cloud Raises $7.4 Million Series A to Transform Commercial Refrigeration using AI

“VieCure’s AI-based decision support platform with its world-leading knowledge library, including standard of care and precision medicine, will enable OCP’s clinicians to give their patients the most appropriate, cost-effective care tailored to their unique circumstances,” said Dr. Fred Ashbury, VieCure’s Chief Scientific Officer.

Recommended AI News: European Manufacturers Seek Transformation Amid Change

[To share your insights with us, please write to sghosh@martechseries.com]